Identification of biomarkers associated with enhanced survival in lung cancer patients undergoing immune checkpoint inhibitor treatment.
INTRODUCTION Immunotherapy has revolutionized lung cancer treatment but has a relatively low response rate. Identification of predictive biomarkers could potentially identify patients for whom response can be expected. In this study, we aim to identify biomarkers from routine lab samples associated with better progress...